Abstract 1847P
Background
With the increasing number of oncologic patients, consultation time per patient shortens, which negatively affects the doctor – patient relationship. Participation in psychotherapeutic groups can help patients gain trust in their treatment. The aim of this study is to quantify the effects of Simonton-training on the psychological state, quality of life and compliance in oncologic patients.
Methods
This survey was carried out at the University of Debrecen in the course of a 12-occasion-long Simonton training. A total of 27 patients in the psychotherapeutic group, and 63 patients in the control group were included in this study. Patients filled out an online questionnaire three times, before the training (t0), right after the training (t1), and again 3 months later (t2). The online questionnaire contained: The Hospital Anxiety and Depression Scale (HADS), WHO Quality of Life 5-item questionnaire (WHO QOL5), Morisky Medication Adherence Scale (MMAS-8) and five questions (5Q) about the general attitude towards their treatment and the trust in their oncologist. The distribution of continuous variables was statistically analysed with the Shapiro-Wilk test, and Wilcoxon test was used for comparisons between the case and control groups due to the non-normal distribution of the majority of variables.
Results
From t0 to t1, the Simonton group’s quality of life significantly increased (p=0,016), meanwhile the control group’s QoL didn’t change significantly (p=0,575). According to HADS scale, the Simonton group’s anxiety significantly decreased from t0 to t1 (p=0,0005), and the change of the control wasn’t significant (p=0,247). Depression values also showed a significant decrease for the Simonton group from t0 to t1 (p=0,003), whereas the control’s depression values didn’t change significantly (p=0,122). After psychotherapy, the Simonton group evaluated their therapy-related attitude better with the 5Q, than at t0 (p=0,026). During this time, the control’s value didn’t change significantly (p=0,532).
Conclusions
On the basis of this study the Simonton training had a positive impact on the patients' psychological state and their quality of life increased.
Clinical trial identification
DE RKEB/IKEB 5773-2021.
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1999P - IMreal Cohort 4: Third interim analysis of efficacy and safety in patients (pts) with extensive-stage small cell lung cancer (ES-SCLC) receiving atezolizumab plus carboplatin and etoposide (atezo + CE) as first-line (1L) therapy under real-world conditions (RWCs)
Presenter: Sanjay Popat
Session: Poster session 05
2000P - Efficacy and safety of thoracic radiotherapy after first-line immunotherapy in extensive stage small cell lung cancer: A multi-center retrospective study
Presenter: Jiake Wu
Session: Poster session 05
2001P - Consolidative thoracic radiotherapy of extensive-stage small cell lung cancer in the era of chemoimmunotherapy: A retrospective analysis concerning patients from southern Italy
Presenter: Vito Longo
Session: Poster session 05
2002P - A multicentre study assessing the real-world effectiveness of first-line chemotherapy plus immunotherapy in extensive-stage small cell lung cancer (ES-SCLC) patients
Presenter: Marie Porte
Session: Poster session 05
2003P - Consolidative intrathoracic radiotherapy during maintenance first-line immunotherapy in extensive stage small cell lung cancer (ES-SCLC): A retrospective multicenter analysis of safety and efficacy
Presenter: Alessio Bruni
Session: Poster session 05
2004P - PD-L1 Inhibitors combined with whole brain radiotherapy in patients with small cell lung cancer brain metastases: Real-world evidence
Presenter: Litang Huang
Session: Poster session 05
2005P - Anlotinib combined with chemotherapy in the treatment of first-line extensive-stage small cell lung cancer (ES-SCLC): A real-world study
Presenter: Fangfang Gao
Session: Poster session 05
2006P - Immune activation effect and survival of different irradiated sites in ES-SCLC patients treated with radioimmunotherapy: A real-world analysis
Presenter: Min Wu
Session: Poster session 05
2007P - Real-world (rw) outcomes to chemoimmunotherapy and biomarker analysis in extensive-stage small cell lung cancer (ES SCLC)
Presenter: Emmanouil Panagiotou
Session: Poster session 05